Eko, a San Francisco, CA-based provider of acoustic cardiac monitoring platform, raised $5m in Series A funding.
The round was led by Artis Ventures, with participation from Strategic Partners, Dreamlt Ventures, 1812 Ventures, and Founder.org.
The company intends to use the funds to grow its commercial team and to expand clinical studies on the use of its platform.
Led by Connor Landgraf, co-founder and CEO, Eko provides a platform of non-invasive cardiac screening devices, care coordination software, and machine learning algorithms that enables more effective screening and management of cardiovascular diseases.
The company’s first FDA-cleared device, CORE, is a smart stethoscope and accompanying platform now used by clinicians at more than 1,000 hospitals and health systems around the globe.